Fast Intracellular Delivery of Proteins, Peptides or Small Molecules
BioCat's partner DIVERSA is a biotech company promoting the transfer of new therapeutic molecules to the clinic through the application of drug delivery nanotechnology. They want to build a bridge between molecules and patients, between drug discovery and clinical application.
DIVERSA aspires to become the company of reference for drug delivery, opening up new opportunities for innovative medicines and improving patients’ lives. They do this by offering ready-to-use formulations for fast intracellular delivery of small molecules and complex macromolecules with high efficiency, while boosting their therapeutic activity. Binding molecules in biocompatible lipid nanoemulsions increases their stability and helps target the right cells in the body.
DIVERSA's proprietary technology is based on lipidic emulsions with an easily controllable size and a narrow distribution. These nanometric emulsions show great stability in different relevant biological fluids and biocompatibility with different cell types as well as in vivo models such as mouse, rat and zebrafish. They have a high loading capacity and are versatile and capable of associating a wide variety of compounds as hydrophobic or amphiphilic small molecules, peptides, proteins, and oligonucleotides (such as DNA and RNA) and deliver them to their target site by overcoming biological barriers.